Firehawkâ„¢ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)
Not Applicable
- Conditions
- Drug-Eluting StentsPercutaneous Coronary InterventionTomography, Optical Coherence
- Interventions
- Device: Firehawk sirolimus target eluting coronary stent systemDevice: XIENCE Everolimus-Eluting Coronary Stent System
- First Posted Date
- 2017-02-02
- Last Posted Date
- 2020-01-10
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 196
- Registration Number
- NCT03040934
- Locations
- 🇨🇳
The General Hospital of Shenyang Military, Shenyang, Liaoning, China
Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation
Phase 4
- Conditions
- Percutaneous Coronary InterventionDrug-Eluting Stents
- Interventions
- Drug: 3 months DAPTDrug: 12 months DAPT
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 2446
- Registration Number
- NCT03008083
- Locations
- 🇨🇳
Shanghai Zhongshan Hospital, Shanghai, China
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II
Not Applicable
Active, not recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Device: XIENCEDevice: Firesorb
- First Posted Date
- 2016-09-07
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 430
- Registration Number
- NCT02890160
- Locations
- 🇨🇳
Fu Wai Hospital, Peking, Beijing, China
The First-In-Man Pilot Study of Firehawk
Not Applicable
Completed
- Conditions
- Coronary Heart Disease
- Interventions
- Device: Rapamycin target-eluting Coronary Stent System
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2019-10-17
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT02688829
Evaluation of New Specifications (38mm) of FirehawkTM in the Treatment of Coronary Heart Disease
Not Applicable
Completed
- Conditions
- Coronary Heart Disease
- Interventions
- Device: Rapamycin target-eluting coronary stent systems (38mm)
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT02688842
- Locations
- 🇨🇳
Fu Wai Hospital, Peking, Beijing, China
Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )
Not Applicable
Completed
- Conditions
- Coronary Heart Disease
- Interventions
- Device: FirehawkTM 2.25mm
- First Posted Date
- 2016-02-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 38
- Registration Number
- NCT02688868
- Locations
- 🇨🇳
Fu Wai Hospital, Peking, Beijing, China
A First-in-Man Study of the Firesorb BVS (FUTURE-I)
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Sirolimus Target Eluting Bioresorbable Vascular Scaffold
- First Posted Date
- 2016-01-20
- Last Posted Date
- 2023-10-25
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT02659254
- Locations
- 🇨🇳
Fu Wai Hospital, Peking, Beijing, China
Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Firehawkâ„¢ stent systemDevice: Abbott Xience family Everolimus-Eluting Stent
- First Posted Date
- 2015-08-11
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 1653
- Registration Number
- NCT02520180
- Locations
- 🇩🇰
Rigshospitalet, Copenhagen, Denmark
Safety and Efficacy Study of MicroPort's Transcatheter Aortic Valve and Delivery System for TAVI
Not Applicable
- Conditions
- Aortic Valve StenosisAortic Valve CalcificationAortic Valve Disease
- Interventions
- Device: MicroPort's Transcatheter Aortic Valve and Delivery System
- First Posted Date
- 2014-08-21
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 89
- Registration Number
- NCT02221921
- Locations
- 🇨🇳
Shanghai Zhongshan Hospital, Shanghai, China
Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: FIREHAWK biodegradable polymer rapamycin-eluting stent
- First Posted Date
- 2011-08-09
- Last Posted Date
- 2019-08-26
- Lead Sponsor
- Shanghai MicroPort Medical (Group) Co., Ltd.
- Target Recruit Count
- 730
- Registration Number
- NCT01412164
- Locations
- 🇨🇳
Fuwai Hospital, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath